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The heparin sulfate proteoglycan Terribly Reduced Optic Lobes (Trol) is the Drosophila melanogaster
homolog of the vertebrate protein Perlecan. Trol is expressed as part of the extracellular matrix (ECM)
found in the hematopoietic organ, called the lymph gland. In the normal lymph gland, the ECM forms
thin basement membranes around individual or small groups of blood progenitors. The pattern of
basement membranes, reported by Trol expression, is spatio-temporally correlated to hematopoiesis. The
central, medullary zone which contain undifferentiated hematopoietic progenitors has many, closely
spaced membranes. Fewer basement membranes are present in the outer, cortical zone, where
differentiation of blood cells takes place. Loss of trol causes a dramatic change of the ECM into a
three-dimensional, spongy mass that ﬁlls wide spaces scattered throughout the lymph gland. At the
same time proliferation is reduced, leading to a signiﬁcantly smaller lymph gland. Interestingly,
differentiation of blood progenitors in trol mutants is precocious, resulting in the break-down of the
usual zonation of the lymph gland. which normally consists of an immature center (medullary zone)
where cells remain undifferentiated, and an outer cortical zone, where differentiation sets in. We present
evidence that the effect of Trol on blood cell differentiation is mediated by Hedgehog (Hh) signaling,
which is known to be required to maintain an immature medullary zone. Overexpression of hh in the
background of a trol mutation is able to rescue the premature differentiation phenotype. Our data
provide novel insight into the role of the ECM component Perlecan during Drosophila hematopoiesis.
& 2013 Elsevier Inc. All rights reserved.Introduction
Animal cells secrete proteins that assemble into an extracel-
lular matrix (ECM). The ECM plays important roles in determining
the mechanical properties of cells and tissues, as well as in
intercellular communication. ECM can also play a role in facilitat-
ing integrin mediated cell interactions (Subramanian et al., 2007).
In many cells, the ECM forms a layered structure called the basal
lamina or the basement membrane. In epithelia, the basement
membrane assembles over the basal cell surface; in other,
mesenchymal tissues, such as muscle or cartilage, basement
membranes surround cells on all sides (Durbeej, 2010). Many
basement membranes are composed primarily of Laminin, type IV
Collagen, Nidogen and heparin sulfate proteoglycans (HSPGs),
which include Perlecan and Agrin (reviewed in Yurchenco et al.,
2004; Laurila and Leivo, 1993). The heparin sulfate chains of these
proteins are mainly responsible for the involvement of basementll rights reserved.
. Grigorian).membranes in cell–cell signaling. They bind (and thereby sequester
or release in a controlled manner) ligands like Fibroblast Growth
Factor (FGF), Platelet Derived Growth Factor (PDGF), Wnt, Hedgehog
(Hh) and Transforming Growth Factor (TGFβ) (Lin, 2004; Lindner
et al., 2007; Yurchenco et al., 2004).
Perlecan is a large macromolecule which consists of a core
protein associated with three glycosaminoglycan side chains and
that occurs in basement membranes around most cells. The core
protein has ﬁve distinct domains. Domains I and V, located at the
N and C terminal sides, respectively, both contain binding sites for
heparin sulfate side chains (reviewed in Whitelock et al., 2008).
These two domains also interact with other ECM proteins, includ-
ing Laminin and Collagen IV, as well cell adhesion molecules, such
as integrins. Domain II is thought to interact with lipids (Fuki et al.,
2000; reviewed in Whitelock et al., 2008). Domains III and IV
interact with other secreted signals and ECM proteins (Friedrich
et al., 1999; Iozzo, 2005; reviewed in Whitelock et al., 2008).
Given its widespread expression in basement membranes and
its ability to bind to a multitude of known adhesion and signaling
molecules, it is to be expected that Perlecan (along with other
HSPGs) plays many different roles in tissue development and
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expectation. In vertebrates, Perlecan plays particularly important
roles in the growth and morphogenesis of the skeleton and
vascular system by modulating cell adhesion and/or the effect of
the signaling molecules FGF, PDGF, and VEGF on chondrocytes,
smooth muscle cells, and endothelial cells (Melrose et al., 2008;
Segev et al., 2004; Whitelock et al., 2008). In Caenorhabditis
elegans, Perlecan mediates the binding of muscle cells to epider-
mal cells via integrins (Rogalski et al., 2001). In Drosophila, the
Perlecan homolog was originally identiﬁed as a mutation affecting
postembryonic growth of the central nervous system. In larvae
carrying this mutation, called trol, neuroblasts show a strongly
decreased rate of proliferation (Datta, 1995). This phenotype was
shown to be mediated by an effect of trol on FGF and Hh signaling
(Caldwell and Datta, 1998; Lindner et al., 2007; Park et al., 2003).
The effect of trol on proliferation is not conﬁned to the CNS;
experiments looking at hemocyte number in trol mutants have
also shown a signiﬁcant drop in circulating plasmatocyte numbers
(Lindner et al., 2007). Further studies have also shown the
expression of trol in the cardioblasts, visceral mesoderm and
hindgut of stage 15 Drosophila embryos (Friedrich et al., 2000).
Comparisons of the human Perlecan gene to trol have found
34% sequence identity in domain III, 24% identity in domain IV
and 30% identity in domain V. No signiﬁcant similarity was seen
in domains I or II (Murdoch et al., 1992; Park et al., 2003).
In Drosophila, Trol is expressed strongly in basement membranes
of embryonic tissues, where it interacts with Laminin and Collagen
(Urbano et al., 2009). It also appears around hemocytes, vascular
cells, and the hematopoietic organ (“lymph gland”) of the late
embryo. Given the reported effect of trol on blood cell number, we
embarked on a more detailed analysis of the role of trol in
Drosophila hematopoiesis.
The blood, or hemolymph, of Drosophila contains three major
types of blood cells (hemocytes), called plasmatocytes, crystal cells
and lamellocytes. Plasmatocytes act as macrophages during devel-
opment, and together with crystal cells, play a role in immunity
and response to injury (Crozatier and Meister, 2007; Martinez-
Agosto et al., 2007). These two cell types comprise the hemocytes
most commonly seen under non-immune challenged conditions.
Lamellocytes are very rare under normal conditions. In cases of
immune challenge, their numbers increase and they act to neu-
tralize objects too large to be phagocytosed.
Hemocytes are produced during two phases of development.
The ﬁrst phase of hematopoiesis takes place in the head meso-
derm of the early embryo; hemocytes produced during this phase
populate the embryo and the circulating hemolymph of the larva.
The second phase of hematopoiesis takes place in the lymph gland
of the larva, a solid hematopoietic organ located alongside the
dorsal vessel (“heart”). The lymph gland derives from a small
population of hematopoietic blood progenitors that ﬁrst appear in
the trunk mesoderm of the embryo, consolidate into the lymph
gland, and then proliferate during the larval stage. By late larval
stages, the lymph gland has grown into a series of several paired
lobes which ﬂank the dorsal vessel. Differentiation of hematopoi-
etic progenitors into mature blood cells takes place in the
periphery (cortex) of the large, anteriorly located primary lobe. A
specialized subpopulation of hemocytes, called the posterior
signaling center (PSC), signal to the medullary zone via the Hh
pathway to maintain cells in an undifferentiated state (Mandal
et al., 2007). Aside from Hh, the Wg signal (expressed in the
medullary zone) and Adenosine deaminase growth factor A (Adgf-
A), produced by differentiating cells in the cortical zone, antag-
onize prohemocyte differentiation (and prolong proliferation) in
the medullary zone (Sinenko et al., 2009; Mondal et al., 2011).
Differentiated hemocytes are released from the lymph gland into
circulation during early metamorphosis (Lanot et al., 2001;Grigorian et al., 2011). During this phase, the entire lymph gland
dissociates; adult ﬂies lack a solid hematopoietic organ. A lymph
gland similar to that described for Drosophila has been documen-
ted for many insects (reviewed in Grigorian and Hartenstein,
2013). Similarities to the hematopoietic tissue of vertebrates are
present; even though a prominent “stroma” (represented in the
vertebrate bone marrow by the network of capillaries and reticular
cells) is missing in invertebrates, cells described as “reticular cells”,
surrounding prohemocytes and possibly acting as stem cells, have
been described in several insect species (Hoffmann et al., 1979). In
all insects investigated, profuse lamellae of ECM, formed by
proteins that are found ubiquitously in basement membranes
and other ECM assemblies of Drosophila and vertebrates
(reviewed in Grigorian and Hartenstein, 2013), were observed.
In this paper, we show that Perlecan/Trol is expressed in
basement membranes that both surround the surface of the lymph
gland and that form discrete chambers within the lymph gland
interior. Loss of trol is associated with a dramatic change in the
texture of the ECM: instead of forming thin membranes around
blood cells, the matrix appears as a spongy mass ﬁlling large areas
of the lymph gland. Concomitantly, proliferation of blood progeni-
tors is reduced, and the lymph gland is signiﬁcantly reduced in
size and cell number. Finally, the altered composition of the ECM
resulting from a loss of trol is associated with premature hemocyte
differentiation. This phenotype can be rescued by the ectopic
expression of Hh. We propose that trol is required for the
organization of the lymph gland ECM, and the proper release
and/or distribution of the Hh ligand throughout the lymph gland.Material and methods
Fly lines
y trol8 w/Bnsn (Park et al., 2001), y trol4 w/Bnsn (Park et al.,
2001), y trolSD w/Bnsn (Datta and Kankel, 1992), ZCL1973X (Kelso
et al., 2004), trol-GFP (Lindner et al., 2007; Medioni and Noselli,
2005; Kelso et al., 2004), domeless-Gal4 (Jung et al., 2005; Mandal
et al., 2007; Ghiglione et al., 2002), Antennapedia-Gal4 (Mandal
et al., 2007; Emerald and Cohen, 2004), elav-Gal4 (Bloomington
Stock Center), Tubulin-Gal4 (Bloomington Stock Center), Collagen-
Gal4 (comprised of a regulatory region, located between the
adjacent collagen type IV genes Cg25C and Viking, fused to a
Gal4; Asha et al., 2003), UAS-trol Rnai (Vienna Drosophila RNAi
Center; ID# 24549), heatshock-hh (hh fused downstream of a
Hsp70 promoter; Ingham, 1993; Park et al., 2003), hhAC
(Bloomington Stock Center), egfrf2 (Bloomington Stock Center),
Oregon R (Bloomington Stock Center), HemolectinΔ-DsRed
(Makhijani et al., 2011).
Immunohistochemistry
α-Antennapedia (Mouse; 1:4; Developmental Hybridoma
Bank), α- BrdU (Rat; 1:100; Abcam), α-Cleaved Caspase 3 (Rabbit;
1:100; Cell Signaling Technology, Inc.), α-Collagen IV (Mouse; 6G7;
1:25–1:50; Murray et al., 1995), α-GFP (Mouse; 1:400; Sigma),
α-GFP (Rabbit; 1:2000; Molecular Probes), α-Laminin (Rabbit;
1:500; Fessler et al., 1987), α-Odd (Rabbit; 1:500; Ward and
Skeath, 2000), α–P1 (Mouse; 1:10; Kurucz et al., 2007), α-Perlecan
domain V (Rabbit; 1:1000; Friedrich et al., 2000), α-Peroxidasin
(Mouse; 1:500; Nelson et al., 1994), α-ProPo (Rabbit; 1:1000;
Muller et al., 1999). All secondary antibodies were acquired from
Jackson Immunoresearch. Both Cy3 and FITC were used at a
dilution of 1:200. Cy5 was used at a dilution of 1:100. Immuno-
histochemistry was carried out following standard protocols
(Ashburner, 1989). Some preparations were counterstained with
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tration of 1:500 to the Vectashield in which the samples were
mounted).
Mutant selection and larval ﬁxation
Trol homozygous mutants were selected during 1st instar stage
via yellow mouth hook color. Larvae were then allowed to mature
on food plate till stated time point. All Larval lymph glands were
dissected by either pulling out mouth hook with the lymph gland
attached or pinning the larva dorsal side down and ﬁlleting it.
Tissue ﬁxed for 20 min in a 1:3 solution of 37% Formaldehyde: 1X
PBS. Lymph glands then washed with 1X PBT (0.1%), 3 times for
15 min each at room temperature while rotating.
BrdU feeding, ﬁxation and staining
56 h larvae were placed on a ﬂy food plate containing 1 mg/ml
of BrdU and left at 25 1C for 30 min. Larvae were then shifted to
regular ﬂy food plates and left at 25 1C until they were dissected at
73 h. Tissue was then ﬁxed in a 1:3 solution of 37% Formaldehyde:
1X PBS for 20–30 min. Staining was carried out as described
previously (Grigorian et al., 2011).
Heatshock
WT, hs-hh, trol8 and hs-hh; trol8 ﬂy lines were allowed to lay
eggs over the weekend on food plates. Larvae were shifted to 37 1C
overnight (food plate was placed upside-down to better withstand
drying). Larvae were then shifted to 29 1C for two days before
being selected, dissected, ﬁxed as described above and labeled
with antibodies. All larvae dissected were 72–132 h post hatching
(raised at 29 1C, except during heat shock).
Electron microscopy
Larval lymph glands were dissected and ﬁxed as described
previously (Grigorian et al., 2011) Blocks were sectioned (60 nm)
and mounted on net grids (Ted Pella). Sections were treated with
uranyl acetate and lead citrate. Samples were sectioned by the
Microscopic Techniques Laboratory and examined using the JEOL
100CX transmission electron microscope at the Electron Micro-
scope Laboratory of the UCLA Brain Research Institute.Results
Trol is a component of the basement membranes that
compartmentalize the lymph gland
In order to assess the expression pattern of trol in the heart and
blood system of Drosophila, we utilized the GFP protein trap line
ZCL1973X (Kelso et al., 2004), as well as an antibody against the
Trol protein (Friedrich et al., 2000). During embryogenesis, Trol
expression becomes visible around cardioblasts at stage 14
(Fig. 1A). By stage 16, Trol expression also surrounds pericardial
nephrocytes and the surface of the lymph gland, a paired cluster of
approximately 30 hematopoietic progenitors (Fig. 1B). Shortly after
larval hatching, Trol covers each individual hematopoietic pro-
genitor of the lymph gland. Expression is particularly strong
around cells of the PSC, labeled with an antibody against Anten-
napedia (Antp) (Fig. 1C C′).
By the 2nd instar (56 h), the lymph gland has expanded, and a
separate central medullary zone (hematopoietic progenitors) has
become morphologically distinct from an outer, more loosely
packed cortical zone, in which some cells show expression ofdifferentiation markers, such as Peroxidasin (Pxn) (Jung et al.,
2005). At the same time, secondary and tertiary lobes appear
posterior to the large primary lobes. Trol expression forms a solid
layer around the surface of primary and secondary lobes. Within
the lobes, Trol expression is seen strongly around clusters of cells;
faint Trol signal appears around individual cells. In other words,
the Trol pattern outlines a system of chambers that each contain
small clusters of hematopoietic progenitors or differentiated
hemocytes. These chambers are smaller in the medullary zone
than in the cortical zone (Fig. 1D-E), and are all but absent in the
secondary/tertiary lobes (Fig. 1E). Two other major components of
basement membranes, laminin and collagen IV, are co-expressed
with Trol in the lymph gland, as seen via antibody staining
(Fig. 1F–G′). It should be mentioned that, while it has been shown
that hemocytes and their progenitors themselves express the
genes encoding these ECM proteins (Knibiehler et al., 1987;
Lunstrum et al., 1988; Kusche-Gullberg et al., 1992), other organs
such as the fat body can also contribute to the ECM of the lymph
gland, as has been demonstrated for the basement membranes of
imaginal discs (Pastor-Pareja and Xu, 2011), and is further sup-
ported by data reported below.
Electron microscopically, the structures containing Trol, Lami-
nin and Collagen IV are revealed as typical basement membranes,
forming 20–40 nm thick, electron dense layers of granular mate-
rial (Fig. 1H–J). Clefts of variable diameter separate basement
membranes and hemocytes. Thus, in many places, basement
membranes adhere closely to the surface of the hemocyte (small
arrow in Fig. 1J). At other locations, basement membranes have
separated from the hemocytes (large arrow in Fig. 1J). Basement
membranes of the lymph gland persist for several hours after
hemocytes are released during the pupal stage (Grigorian et al.,
2011), attesting to the fact that these membranes are extraordi-
narily stable structures.
The chambered appearance of the basement membranes
appears to be related to hemocyte proliferation. Thus, short pulses
of BrdU fed to larvae, followed by a chase, resulted in 4–8 cell
clones of labeled cells which frequently coincided with chambers
(Fig. 2A–D). We propose a process where Trol (and other ECM
proteins) is continuously secreted by a hematopoietic progenitor
to form a basement membrane around the cell. As the hematopoi-
etic progenitor divides, the newly formed membranes in between
the daughter cells initially lack a coat of ECM, whereas this coat is
already present on all other sides. In this manner, as proliferation
continues, the membranes facing the “inside” of the clone are
thinner (small arrow in Fig. 2D) than those facing the outside
(large arrow in Fig. 2D)Loss of trol causes a change in the ultrastructure of the lymph
gland ECM
In order to assess the role of trol in hematopoiesis, we
investigated three loss of function alleles, trolSD, trol4 and trol8
(Lindner et al., 2007). trol8 (the allele used in the following for
phenotypic analysis) showed a complete loss of Trol protein
expression (Fig. 3D), whereas residual Trol signal, visible as a
sheath encasing the lymph gland, remained in the other two
alleles (Fig. 3B,C). To learn more about the tissue-speciﬁc require-
ment of trol, we used the UAS-Gal4 system to drive a trol-RNAi
construct with domeless (dome)-Gal4 (medullary zone, but also
nervous system; Fig. 3E), Antennapedia (Antp)-Gal4 (PSC; not
shown); Hemolectin (Hml)-Gal4 (cortical zone; not shown),
Collagen (Cg)-Gal4 (cortical zone, fat body; Fig. 3 F), Tubulin
(Tub)-Gal4 (ubiquitous; Fig. 3G), and elav-Gal4 (brain; Fig. 3H).
Ubiquitous and medullary zone-directed expression of trol-RNAi
Fig. 1. Expression of Perlecan/Trol in the lymph gland and dorsal vessel. A-B: Dorsal view of stage 14 (A) and stage 16 (B) embryos. Trol expression is visualized by GFP
(green) driven by the ZCL1973X line. The lymph gland (lg) and pericardial cells (pc) are also labeled with anti-Odd antibody (red). Nuclei are labeled with Sytox (blue). C:
First instar larva (4–6 h post hatching). Trol expression has increased and starts to surround individual hematopoietic progenitors (arrowhead). The Posterior Signaling
Center (PSC) is labeled with anti-Antennapedia (Antp; red) antibody. Nuclei are labeled with Sytox (blue). D: Second instar larva (56 h post hatching). Trol expression
increases and becomes more concentrated in the center of the lymph gland, the incipient medullary zone (mz). E: Third instar larva (96 h post hatching). Trol expression is
strong in the medullary zone and outlines chambers that include multiple cells (arrowhead; see also Fig. 2). Expression is diminished in cortical zone (cz) where hemocytes,
labeled here by anti-Peroxidasin (Pxn; red) differentiate. F–G: Co-expression of Trol (green) with Laminin A (F,F′) and Collagen IV (G,G′), recognized by their respective
antibodies (red) in the extracellular matrix of late larval lymph gland. H-J: Electron micrographs of third instar larval lymph gland. Basement membranes surround individual
hematopoietic progenitors (ph; small arrow in J) and form irregular septa around groups of cells (large arrow in J. H: Used with permission from Grigorian et al., 2011). Other
abbreviations: cb cardioblasts; dv dorsal vessel; lgpl primary lobe of lymph gland; lgsl secondary lobe of lymph gland. Bars: 20 μm (A–D; E–F); 5 μm (G).
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Fig. 2. Pattern of basement membranes in lymph gland is related to hematopoietic progenitor proliferation. A,B: Two confocal section of a ZCL1973X, 72 h larval lymph gland
showing expression of trol (green), anti-BrdU (red), and Sytox (blue). Larva had been subjected to 1 h pulse of BrdU at 48 h. C,D: High magniﬁcation view of BrdU-positive
cells (red in C) in relationship to trol-positive basement membranes (green in C; white in D). BrdU-positive hematopoietic progenitors form clusters of cells whose
boundaries, in most cases, coincide with the septa formed by basement membranes (arrowheads in A,B; large arrows in C,D). Individual cells are surrounded by thin
basement membranes (small arrows in C,D). Bar: 40 μm (A,B); 10 μm (C,D).
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lymph gland; by contrast, trol-RNAi driven by Cg-Gal4 and elav-
Gal4 did not have a signiﬁcant effect on Trol expression in the
lymph gland.
The most conspicuous phenotype of trol LOF alleles is a reduced
lymph gland size and altered packing of prohemocytes. Light
microscopically, the lymph gland of trol mutants showed large
gaps (lacunae) devoid of cells (arrows in Fig. 4B′,D′). A similar
phenotype could be observed when expressing trol-RNAi ubiqui-
tously by Tub-Gal4 (not shown). Laminin and Collagen IV, normally
concentrated in thin basement membranes surrounding (groups
of) hemocytes (Fig. 4A, C), occupied these lacunae in between
strands of cells (Fig. 4B, D). Electron microscopically, these lacunae
were solidly ﬁlled with a ﬁne-meshed, reticular material (Fig. 4E).
At the same time, thin basement membranes around individual
cells, or the lymph gland as a whole, were absent. In electron
density, the reticular ECM of trol mutant lymph glands resembled
the basement membranes of wild type (compare panels in
Fig. 4F–I). The main difference is best characterized as a change
in pattern: in wild type, the macromolecular components of the
ECM assemble as a two-dimensional sheet (Fig. 4F–G). In the
absence of trol, these components are woven into a three-
dimensional network of lamellae and ﬁbers (Fig. 4H–I).
Loss of trol results in a reduction of proliferation and premature
differentiation of hemocytes
The lymph glands of trol mutant larvae are smaller than their
wild-type counterparts. Past studies have shown that cell cycle
progression in the brain of trol mutants is arrested (Caldwell and
Datta, 1998). We therefore carried out BrdU incorporation studies
in order to assess whether cell proliferation was reduced in trol8
mutant lymph glands. We found that 48 h and 72 h trol8 lymphglands had lower levels of BrdU incorporation in comparison to
their WT counterparts (Fig. 5A–D). To verify that the lower
numbers of BrdU positive cells seen in trol8 mutant lymph glands
was not due to overall loss in size of the lymph gland, we
quantiﬁed the percentage of BrdU positive cells in comparison to
the overall volume of lymph gland size in mutant and WT 48 h to
72 h lymph glands. Average percentage of BrdU positive cells is
19.18% (SD 5.3%) in trol8 vs. 44.2% (SD 4.6%) in WT (p value:
0.000186277; t-test: 1 tail, type 2). Since changes in size could also
be due to cell death, we carried out an anti-cleaved Caspase-3
staining in mutant lymph glands, however no noticeable cell death
was seen (Supplemental Fig. 1).
Signiﬁcantly, the reduction in proliferation is accompanied by a
premature differentiation of hemocytes. Late differentiation markers
of plasmatocytes, like P1 which is expressed only in the late third
instar (96–120 h) of wild type larvae, appeared as early as 72 h post
hatching in trol mutants (Fig. 5D). Furthermore, in mutant lymph
glands, the zonation into a central medullary zone containing
undifferentiated hematopoietic progenitors, surrounded by a cortical
zone of differentiating hemocytes was abolished. Differentiation
markers like P1(late plasmatocytes), Pxn (early plasmatocytes), or
ProPo (crystal cells) were evenly distributed throughout the lymph
gland (Fig. 5E-F,I–L). Ubiquitous activation of trol-RNAi (tub-Gal4) had
a similarly strong effect in regard to precocious differentiation of
hemocytes (Fig. 5M). A milder phenotype could be elicited by knock-
down of trol via an RNAi construct driven by dome-Gal4 (medullary
zone; Fig. 5N, O) or cg-Gal4 (cortical zone plus fat body; Fig. 5P).
Knockdown of trol in the cortical zone alone or in the brain had no
signiﬁcant effect on hemocyte differentiation (Fig. 5Q).
The loss of function and knock-down phenotype suggests that
the block of differentiation that is normally exerted onto the
medullary zone by signals from the PSC and the cortical zone is
lifted. To assay for the presence of the PSC we used an antibody
Fig. 3. A–D: Expression of Trol antibody (green) in 96 h wild-type lymph gland (A) and three mutant trol alleles: trolSD (B), trol4 (C) and trol8 (D). Of the three mutants only
trol8 shows a complete lack of anti-Trol antibody staining. E–H: Expression of trol-RNAi by four different Gal4 driver lines. Pattern of expression of the drivers (E: domeless
(dome)-Gal4; F: Collagen (Cg)-Gal4; G: Tubulin (tub)-Gal4; H: elav-Gal4) is shown schematically at right of panels; Trol signal in lymph gland, detected by antibody, is showing
at the left. Note that, within the lymph gland, Cg-Gal4 is almost exclusively expressed in the cortical zone, even though collagen protein is detected by antibody staining in
both cortical and medullary zones; see Fig. 1G,G′. Abbreviations: cz cortical zone; dv dorsal vessel; mz medullary zone; Bar: 20 μm (A–H).
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Fig. 4. Loss of trol causes structural changes in extracellular matrix of lymph gland. A–D: confocal sections of 96 h wild-type lymph gland (A,C) and trol8 mutant (B,D) labeled
with anti-Laminin (A,B) and anti-Collagen IV antibodies (C,D). B′ and D′ show higher magniﬁcations of mutant lymph glands presented in B and D, respectively. Laminin and
Collagen IV are distributed in thin layers (basement membranes) in wild type; in trol8 mutants, these proteins solidly ﬁll wide extracellular spaces formed within the lymph
gland (arrows in B′ and D′). In addition, brightly labeled “puncta” (yellow arrowhead in D′) appeared consistently in lymph glands labeled with anti-Collagen IV, but not anti-
Laminin. E: Electron micrograph of trol8 mutant lymph gland. Wide clefts in between clusters of hematopoietic progenitors (ph) are ﬁlled with extracellular matrix (ecm).
F, G: High magniﬁcation electron micrographs of extracellular matrix of wild-type lymph gland, forming thin, two-dimensional basement membranes around cells. H,I: In
trol8 mutant, extracellular matrix is structured as a three-dimensional meshwork of ﬁbers and membranes. Other abbreviations: cc crystal cell; dv dorsal vessel; ph
hematopoietic progenitor. Bars: 20 μm (A–D′); 5 μm (E); 200 nm (F,H); 100 nm (G,I).
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Fig. 5. Loss of trol leads to reduced proliferation and precocious differentiation of hematopoietic progenitors. A–D: 1 h pulses of BrdU were applied to wild-type larvae (A,C) and
trol8 mutant larvae (B,D). Larvae were sacriﬁced at time points indicated (48 h after hatching: A,B; 72 h: C,D). Lymph glands were labeled with anti-BrdU (red) and anti-P1 (green).
BrdU-positive cells are strongly reduced in trolmutants at both time points. The plasmatocyte marker P1 is not yet expressed in 72 h wild-type lymph glands (C), but labels clusters
of cells in the trol8 mutant lymph gland (D). E–L: Expression of hemocyte differentiation markers in lymph glands of 96 h wild-type and trol8 mutant larvae. In 96 h wild-type
lymph glands, early hemocyte marker peroxidasin (Pxn, red in E), late plasmatocyte marker P1 (green in I) and crystal cell marker Propo (green in K) are restricted to the cortical
zone (cz). These markers are evenly expressed throughout the lymph glands of 96 h trol8 mutants (F,J,L). Antp, a marker for the PSC (green in G,H) is expressed normally in the trol8
mutant. M-Q: Driving a trol-RNAi construct with different driver lines [Tubulin (Tub)-Gal4 (M), dome-Gal4 (N,O), Collagen (Cg)-Gal4 (P), elav-Gal4 (Q)] results in precocious
expression of differentiation markers (M,N,P;P1: green; Peroxidasin (Pxn) or Hemolectin (Hml): red). Hml expression seen via a reporter line (HmlΔ-DsRed) crossed into the stated
background. Bar:20 μm (A–Q). Other Abbreviations: cz cortical zone; mz medullary zone; dv dorsal vessel; pl primary lobe; psc posterior signaling center.
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remained unchanged (Fig. 5G,H) in regard to level and cell
number, indicating that the premature differentiation of the
medullary zone is not the result of a lack of the PSC.Loss of trol interferes with the Hh signaling pathway
Hh signaling plays an important role in determining hemocyte
differentiation within the lymph gland. Hh signals originating
from the PSC maintain cells of the medullary zone in an undiffer-
entiated state (Mandal et al., 2007). Loss of this signal results in
mass differentiation of the cells of the lymph gland. Trol is known
to play a role in modulating molecular signals, including Hh. Since
we had observed a phenotype where the cells of the trol8 mutant
lymph glands were differentiated regardless of their location in a
medullary or cortical zone, we decided to look into whether trol
may be effecting Hh signaling.
The expression level of the receptor Patched (Ptc), which is also
utilized as a read-out for Hh-signaling activity, was reduced in the
medullary zone (Fig. 6A,C). The transcription factor Cubitus inter-
ruptus (Ci), which is activated by Hh signaling from the PSC, and is
normally expressed in the medullary zone (Mandal et al., 2007),
was also strongly reduced or absent in the trol8 mutant (Fig. 6B,D).
Both ﬁndings indicate that in the absence of trol, Hh signaling to
the medullary zone is diminished. Genetic interaction between hh
and trol further support this notion. We used the heat-shock
inducible hs-hh construct (Ingham, 1993; Park et al., 2003) in the
background of homozygous trol larvae to test the prediction that
overexpression of hh will rescue the trol hemocyte differentiation
phenotype in the lymph gland. Expression of the hs-hh construct
alone in wild-type larvae caused a delay in hemocyte differentia-
tion compared to WT (Fig. 6E-F). This was expected based on past
studies that have shown that Hh acts to maintain lymph gland
hematopoietic progenitors in an undifferentiated state (Mandal
et al., 2007). Expressing hs-hh in the background of trol LOF
animals rescued the global, premature differentiation of primary
lobes characteristic for the trol mutant (compare Fig. 6G and H,I).
Lymph glands were still reduced in size and showed wide, cell-free
gaps, but contained no differentiated cells in their central domain
(“medullary zone”). P1 was almost entirely absent; Pxn was
expressed in clusters of hemocytes restricted to the periphery
(“cortical zone”) of the lymph gland (data not shown). These
results suggest a model where the Hh signal, in order to act on
cells of the medullary zone, requires the presence of the ECM
protein Trol. Loss of Trol renders endogenous Hh ineffective;
however, by applying Hh in excess by utilizing hs-Hh, its role as
an inhibitor of differentiation can be partially restored.
To further test an interaction between Trol and Hh, trol8 and
hhAC lines were crossed and progeny heterozygous for both
alleles were examined to view a possible ampliﬁcation of phe-
notype. Using P1 as a differentiation marker, primary lymph
glands of heterozygous trol8, hhAC and trol8/hhAC were examined.
All heterozygote mutants had mild precocious differentiation
within the primary lobes. However, a marked ampliﬁcation of
the phenotype was observed in the secondary lobes of the double
heterozygotes over the simple heterozygotes. In WT animals,
secondary lobe cells of the pupa disperse before expression of P1Fig. 6. Genetic interaction between trol and Hh signaling pathway members. A–D:
Genes activated by Hh signaling, patched (ptc; A) and cubitus interruptus (ci; B) are
expressed in medullary zone (mz) of 96 h wild-type lymph gland (Ptc and Ci
proteins recognized by antibodies; red). Expression levels of these genes are
strongly reduced in trol8 mutant (C,D). E–I: Precocious differentiation of hemocytes
in trol can be rescued by ectopic hh expression. All panels show lymph glands of
late third instar larvae which have been heat shocked (see Material and Methods).
E: In wild-type lymph glands, hemocyte differentiation is initiated in the cortical
zone, as shown by expression of the crystal cell marker Propo (red) and the late
plasmatocyte marker P1 (green). F: Larvae expressing hs-hh in a wild-type back-
ground show reduced hemocyte differentiation in comparison to the WT. G: In a
trol8 mutant that has been heat shocked, both Propo and P1 are expressed
throughout the lymph gland. H,I: Expression of hs-hh in the background of trol8
(note absence of Trol protein shown in I) prevents hemocyte differentiation. Bar:
20 μm (A–E). Other abbreviations: cz cortical zone; lg lymph gland. Bars: 20 μm.
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trol8 and hhAC heterozygotes showed few P1 positive cells, the
secondary lobes of trol8/hhAC double mutants showed a marked
increase in P1 positive cells (Supplemental Fig. 2).Discussion
Perlecan/Trol is a secreted heparin sulfate proteoglycan (HSPG)
that forms a widespread component of the ECM. Members
of the HSPG family are comprised of a protein core to which
heparin sulfate glycosaminoglycan chains are attached (Bernﬁeld
et al., 1999; Esko and Selleck, 2002; reviewed in Yan and Lin,
2009). A number of genes encoding glycosyltransferases and
modiﬁcation enzymes that include tout-velu (ttv), sister of ttv
(sotv), brother of ttv (botv) and sulfateless (sﬂ) are conserved
from vertebrates to Drosophila, and are important for the poly-
merization and modiﬁcation of heparin sulfate chains during
their biosynthesis (Esko and Selleck, 2002; Nybakken and
Perrimon, 2002; Lin and Perrimon, 2002; reviewed in Yan and
Lin, 2009). Loss of these enzymes has been shown to lead to
defective morphogen signaling and gradient formation, showing
the importance of heparin sulfate chains for the role of HSPGs in
the ECM.
Our study of Drosophila Perlecan/Trol shows that this protein
plays an important role in Drosophila hematopoiesis. Trol is
expressed in the hematopoietic organ, the lymph gland, from
embryonic stages onward. As shown in our previous work
(Grigorian et al., 2011) and in this paper, the ECM of the lymph
gland forms thin lamellae (“basement membranes”) surrounding
individual hemocytes, as well as the organ as a whole. A similar
organization of the ECM has also been noted in the hematopoietic
organs of other insects (Hoffmann et al., 1979; Nardi et al., 2003;
Grigorian et al., 2011). For example, in Locusta migratoria,
Hoffmann et al. (1979) describe “ﬁne lamellae of basement
membrane” around the hemocytes. The basal laminae within the
Manduca hematopoietic organ also seem to form chambers around
hemocytes; Nardi et al. (2003) describe groups of contiguous cells
within the hematopoietic organ that appear to be tightly held
together by basal laminae, thereby somewhat separating them
from more loosely associated single cells that are also found in the
organ. As hemocytes move from the hematopoietic organ into
circulation, they locally break through this ECM (Grigorian et al.,
2011). Similarly, in Manduca sexta, the basal lamina surrounding
the hematopoietic organ shows gaps in the domain where hemo-
cytes are released (Nardi et al., 2003).
Drosophila trol mutants exhibit a complex lymph gland pheno-
type. We speculate that this phenotype is caused by (1) the role of
Trol as a structural component of the ECM, and (2) its role as a
binding partner to extracellular signals, such as Hh. In regard to
the ﬁrst role, we observed an anomalous ultrastructure of the
lymph gland ECM, which forms a sponge-like, three dimensional
mesh, as opposed to the two-dimensional lamellae seen in the
wild type. Correspondingly, the distribution of Laminin and
Collagen IV is also affected in trol mutants. Instead of forming
the lamellae characteristically seen in wild type, Collagen IV and
Laminin are distributed diffusely throughout the wide lacunar
spaces that riddle the trol-mutant lymph gland. This ﬁnding
suggests that Trol exerts an organizing effects on other constitu-
ents of the ECM, such as Laminin and Collagen. Converse
studies, looking at Trol protein in the background of deﬁciencies
of other ECM components, have revealed that a mutation in
laminin β1 chain causes a loss of both Collagen IV and Trol
accumulation around the cardioblasts of D. melanogaster embryos
(Urbano et al., 2009). Collagen IV mutants in D. melanogaster also
lose Trol in the basement membranes of embryos and larval wingdiscs (Pastor-Pareja and Xu, 2011). A recent study (Pastor-Pareja
and Xu, 2011) investigated the function of trol during wing
disc development using trol-RNAi. This treatment did not cause
the loss of Collagen IV or Laminin. Structurally, trol-RNAi
reduced the thickness of the wing disc basement membrane. The
mesh-like ECM phenotype that we witnessed in the trol8 mutant
larval lymph gland was not observed in the wing disc. In the
lymph gland, knocking down trol via dome-RNAi also causes only
slightly premature expression of the hemocyte differentiation
markers Pxn and P1, but does not have an apparent effect on
general ECM structure (this study; Dragojlovick-Munther and
Martinez-Agosto, this issue). On the other hand, driving the trol-
RNAi construct ubiquitously (Tub-Gal4) results in a much stronger
phenotype, pointing to the importance of tissues outside the
lymph gland in shaping the ECM surrounding hemocytes and
their progenitors. Previous work has shown that the basement
membranes surrounding a number of larval structures, notably
the imaginal discs, are assembled from ECM produced in the fat
body, rather than the epithelial cells of the discs themselves
(Pastor-Pareja and Xu, 2011). It is likely that the basement
membranes surrounding hemocytes in the lymph gland may also
be enriched by proteins diffusing from the fat body, via the
hemolymph, into the glands. The lack of any lymph gland
phenotype when knocking down Trol in the brain (elav-Gal4)
demonstrates that general neurological abnormalities, which
might have an indirect effect on growth and metabolism, did not
account for the strong lymph gland phenotype seen in trol LOF
alleles and RNAi knockdowns.
In vertebrates, Perlecan binds to Laminin and Collagen
(Whitelock et al., 2008) and is known to play a role in Laminin
organization in mouse embryonic stem cells (Henry et al., 2001).
Perlecan is also involved in cartilage matrix assembly and has
been seen to promote collagen ﬁbril formation (Kvist et al., 2006).
On the organismic level, mutations in vertebrate Perlecan have
a profound effect on blood and cardiovascular development.
Morpholino-mediated knockdown of Perlecan in zebraﬁsh showed
abnormal development of the angiogenic intersegmental and
dorsal longitudinal anastomotic vessels (Zoeller et al., 2008).
Knock-out of Perlecan in mice causes a pleiotropic phenotype
(Arikawa-Hirasawa et al., 1999; Costell et al., 1999; reviewed in
Whitelock et al., 2008), reﬂecting the fact that Perlecan is
expressed in many different tissues throughout development. In
the cardiovascular system, Perlecan KO mice show massive blood
leakage into the pericardial cavity (Sasse et al., 2008). Further
vascular defects include abnormal coronary vessels, as well as
transposition of the great arteries (Hassell et al., 2002). Perlecan is
also a component of the ECM in bone marrow (Klein et al., 1995),
where it is expressed strongly between maturing hematopoietic
cells, as well as in the basement membrane of endothelial cells.
Perlecan is thought to interact closely with proliferating and
differentiating hematopoietic cells. Interestingly, in vitro cell
attachment assays indicate that Perlecan appears to reduce the
adhesion of hematopoietic cells (Klein et al., 1995). This role as a
repellant for hematopoietic cells may be important for the
regulation of cell migration and egress into circulation.
Aside from the structural defects, loss of function in Perlecan or
other glycoproteins causes defects that are attributable to disrup-
tions in signaling mechanisms. These observations emphasize the
(permissive) role of ECM components in shaping the pattern of
release and the concentration gradients of secreted signals. We
report here that the lymph glands are signiﬁcantly smaller in size
than their WT counterparts due to reduced cell divisions. This
phenotype is reminiscent of the reduced proliferation in larval
brain neuroblasts that gave the trol mutation (“terribly reduced
optic lobes”) its name (Datta and Kankel, 1992). In the larval brain,
trol promotes cell cycle progression of neuroblasts via the FGF and
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Lindner et al., 2007). Datta and colleagues also noted a signiﬁcant
drop in the number of circulating larval hemocytes in the trol
mutant (Lindner et al., 2007), and speculated that trol promotes
Ras-MAPK via the Pvr (PDGF/VEGF) signaling pathway, which has
been shown to play a role in hemocyte maintenance in the embryo
(Bruckner et al., 2004). It is conceivable that the reduced pro-
liferation in the trol mutant larval lymph gland described in this
paper is also mediated via an effect of Trol on PVR signaling.
Published ﬁndings demonstrate that PVR signaling plays a role in
relaying a signal between the PSC and the cortical zone that is
important in maintaining cells of the medullary zone in an
undifferentiated state (Mondal et al., 2011). No data exist to date
to settle an earlier role of PVR in prohemocyte proliferation during the
early larval stage. However, FGFR signaling plays a role in this
process, and interacts with Trol (Dragojlovick-Munther and Martinez-
Agosto, this issue).
A further characteristic phenotype of the trol mutation is
precocious differentiation of the hematopoietic progenitors of
the lymph gland. Whereas P1 expression is seen by 72 h in the
trol8 mutant, WT lymph glands do not show expression of this
marker until 96 h. In addition to its early onset, differentiation is
not limited to the cortical zone of the lymph gland, as is seen in
WT, but occurs in the medullary zone as well. In the lymph
gland of D. melanogaster larvae, Hh is known to play a role in
maintaining the cells of the medullary zone in an undifferentiated
state (Mandal et al., 2007). Our ﬁndings indicate that the pre-
cocious and disordered differentiation observed in trol lymph
glands is indeed due to a reduced activity in Hh signaling,
prompting the hypothesis that Hh, secreted from the PSC, requires
Trol and/or an intact ECM to act upon the medullary zone.
Previous studies have shown that Perlecan can bind Hh, Wnt
and FGF, thereby controlling the concentration of these molecules
in the pericellular space and the amount of signal that is received
by cells (reviewed in Iozzo, 2005; Whitelock et al., 2008). In other
words, Perlecan and other glycoproteins of the ECM shape the
gradient of Hh and other morphogens. In the wing disc, mutant
clones of the glycosyltransferase ttv exhibit impaired Hh signaling.
Hh appears to be unable to diffuse past these mutant cells
(Bellaiche et al., 1998). Clones carrying a double mutation for the
Drosophila HSPG glypicans division abnormally delayed (dally)
and dally-like-protein (dlp) show a similar, albeit weaker pheno-
type to that seen for ttv (Han et al., 2004; reviewed in Yan and Lin,
2009). Furthermore, co-immunoprecipitation studies in third
instar larvae of D. melanogaster demonstrate a direct interaction
between Trol and Hh (Park et al., 2003). Lipid-modiﬁcation of Hh is
needed for its interaction with HSPGs (Bellaiche et al., 1998;
Callejo et al., 2006; Gallet et al., 2006; reviewed in Yan and Lin,
2009). Another way of picturing the involvement of Trol in Hh
signaling is to view the ECM as a physical conduit for the normal
spreading of Hh. Even under normal circumstances, ECM acts as a
migration and diffusion barrier (Korpos et al., 2010; Sabeh et al.,
2004). The altered state of the ECM in trol mutant lymph glands
may further inhibit proper Hh dispersion. We propose that the
Drosophila larval lymph gland, with its simple structure and highly
characteristic lamellar ECM architecture, represents a favorable
system to approach genetically the role of ECM in cell–cell
signaling pathways.Acknowledgments
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